Clinical Trials Logo

Multiple Sclerosis clinical trials

View clinical trials related to Multiple Sclerosis.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT03822858 No longer available - Multiple Sclerosis Clinical Trials

Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

Start date: n/a
Phase:
Study type: Expanded Access

To give expanded access to intrathecal autologous MSC-NP treatment to patients with progressive MS who do not meet the inclusion/exclusion criteria of our Phase II stem cell trial.

NCT ID: NCT02807285 No longer available - Multiple Sclerosis Clinical Trials

Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Start date: n/a
Phase: N/A
Study type: Expanded Access

The primary objective of this expanded access program is to provide ocrelizumab as treatment for eligible participants with primary progressive multiple sclerosis (PPMS) before it is commercially available in the United States (U.S.) for the indication of PPMS.

NCT ID: NCT02084121 No longer available - Clinical trials for Metachromatic Leukodystrophy

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Start date: n/a
Phase:
Study type: Expanded Access

A subject was treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rather than the Max Sep (Baxter) device.